ALRIB Stock Analysis: Riber S.A | PA
Semiconductor Equipment & Materials | PA, France | Market Cap: 209m EUR | 12M Return: 189.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.01M
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Riber S.A. is a French supplier of molecular beam epitaxy (MBE) equipment, components, and related services for the compound semiconductor industry. The company offers a broad product portfolio spanning MBE systems (for research and pilot production), real-time curvature measurement tools, laser passivation systems, and a wide range of MBE consumables such as effusion cells, gas and valved sources, resistive cells, and valved cracker sources, along with heaters, manipulators, accessories, OEM components, and software. Riber serves a diverse set of end markets, including power and RF electronics, lasers, IR detectors, displays, passivation, materials, solar, and OEM customers, and has been operating in this field since its founding in 1964.
MBE is a highly specialized epitaxial deposition technique used to grow ultra-pure, precisely controlled crystalline layers, which is a niche but technologically critical segment of the broader semiconductor materials and equipment value chain. As a pure-play MBE equipment vendor, Ribers business model is tied to capital investment cycles at research institutes and compound semiconductor manufacturers, as well as recurring revenue from replacement sources, components, and service contracts.
- Compound semiconductor demand drives MBE system orders
- R&D spending cycles create lumpy quarterly revenue
- MOCVD competition pressures MBE equipment market share
| Net Income: 5.24m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -3.56 > 1.0 |
| NWC/Revenue: 40.35% < 20% (prev 33.94%; Δ 6.41% < -1%) |
| CFO/TA 0.08 > 3% & CFO 4.52m > Net Income 5.24m |
| Net Debt (-5.39m) to EBITDA (5.84m): -0.92 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago 1.07% < -2% |
| Gross Margin: 38.71% > 18% (prev 35.44%; Δ 3.27% > 0.5%) |
| Asset Turnover: 76.58% > 50% (prev 82.52%; Δ -5.94% > 0%) |
| Interest Coverage Ratio: 146.9 > 6 (EBIT TTM 4.99m / Interest Expense TTM 34.0k) |
| A: 0.29 (Total Current Assets 43.6m - Total Current Liabilities 27.4m) / Total Assets 55.4m |
| B: 0.09 (Retained Earnings 5.24m / Total Assets 55.4m) |
| C: 0.09 (EBIT TTM 4.99m / Avg Total Assets 52.6m) |
| D: 0.97 (Book Value of Equity 27.3m / Total Liabilities 28.1m) |
| Altman-Z'' = 3.89 = AA |
| DSRI: 1.93 (Receivables 18.0m/9.50m, Revenue 40.3m/41.2m) |
| GMI: 0.92 (GM 35.44% / 38.71%) |
| AQI: 0.96 (AQ_t 0.13 / AQ_t-1 0.14) |
| SGI: 0.98 (Revenue 40.3m / 41.2m) |
| TATA: 0.01 (NI 5.24m - CFO 4.52m) / TA 55.4m) |
| Beneish M = -2.37 (Cap -4..+1) = BBB |
As of July 09, 2026, the stock is trading at EUR 9.71 with a total of 168,595 shares traded. Over the past week, the price has changed by -15.12%, over one month by -28.68%, over three months by +37.24% and over the past year by +189.51%.
Current recommended Stop Loss: 8.50 (which is 12.5% or 1.2 ATR below the current price).
Riber S.A has no consensus analysts rating.
P/E Trailing = 39.76
P/E Forward = 25.3165
P/S = 5.1846
P/B = 8.6866
P/EG = 10.9615
Revenue TTM = 40.3m EUR
EBIT TTM = 4.99m EUR
EBITDA TTM = 5.84m EUR
Long Term Debt = 94.0k EUR (from longTermDebt, last quarter)
Short Term Debt = 1.48m EUR (from shortTermDebt, last quarter)
Debt = 2.09m EUR (from shortLongTermDebtTotal, last quarter) + Leases 350k
Net Debt = -5.39m EUR (calculated: Debt 2.09m - CCE 7.47m)
Enterprise Value = 203.6m EUR (209.0m + Debt 2.09m - CCE 7.47m)
Interest Coverage Ratio = 146.9 (Ebit TTM 4.99m / Interest Expense TTM 34.0k)
EV/FCF = 70.05x (Enterprise Value 203.6m / FCF TTM 2.91m)
FCF Yield = 1.43% (FCF TTM 2.91m / Enterprise Value 203.6m)
FCF Margin = 7.21% (FCF TTM 2.91m / Revenue TTM 40.3m)
Net Margin = 13.0% (Net Income TTM 5.24m / Revenue TTM 40.3m)
Gross Margin = 38.71% ((Revenue TTM 40.3m - Cost of Revenue TTM 24.7m) / Revenue TTM)
Gross Margin QoQ = 39.63% (prev 36.15%)
Tobins Q-Ratio = 3.68 (Enterprise Value 203.6m / Total Assets 55.4m)
Interest Expense / Debt = 1.63% (Interest Expense 34.0k / Debt 2.09m)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = 3.75m (EBIT 4.99m * (1 - 25.00%))
Current Ratio = 1.59 (Total Current Assets 43.6m / Total Current Liabilities 27.4m)
Debt / Equity = 0.08 (Debt 2.09m / totalStockholderEquity, last quarter 27.3m)
Debt / EBITDA = -0.92 (Net Debt -5.39m / EBITDA 5.84m)
Debt / FCF = -1.85 (Net Debt -5.39m / FCF TTM 2.91m)
Total Stockholder Equity = 22.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.96% (Net Income 5.24m / Total Assets 55.4m)
RoE = 22.89% (Net Income TTM 5.24m / Total Stockholder Equity 22.9m)
RoCE = 21.73% (EBIT 4.99m / Capital Employed (Equity 22.9m + L.T.Debt 94.0k))
RoIC = 13.63% (NOPAT 3.75m / Invested Capital 27.5m)
WACC = 13.62% (E(209.0m)/V(211.1m) * Re(13.74%) + D(2.09m)/V(211.1m) * Rd(1.63%) * (1-Tc(0.25)))
Discount Rate = 13.74% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 20.0 | Cagr: 1.03%
[DCF] Terminal Value 56.16% ; FCFF base≈3.50m ; Y1≈3.07m ; Y5≈2.48m
[DCF] Fair Price = 1.28 (EV 21.5m - Net Debt -5.39m = Equity 26.9m / Shares 21.0m; r=13.62% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 61.67 | Revenue CAGR: 7.47% | SUE: -0.08 | # QB: 0
EPS current Year (2026-12-31): EPS=0.26 | Chg30d=-3.81% | Revisions=-25% | GrowthEPS=+4.0% | GrowthRev=+5.0%
EPS next Year (2027-12-31): EPS=0.46 | Chg30d=+34.58% | Revisions=+25% | GrowthEPS=+76.9% | GrowthRev=+26.2%